Imclone Systems, A Wholly-owned Subsidiary Of Eli Lilly And Company
Overview
Imclone Systems, A Wholly-owned Subsidiary Of Eli Lilly And Company is a biotechnology company based in United States, with approximately 1,001 employees.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Imclone Systems, A Wholly-owned Subsidiary Of Eli Lilly And Company in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.